课题基金 / 基金详情

Cancer Control and Survivorship Program

Cancer Control and Survivorship Program
癌症控制和生存计划
批准号:
10378575
负责人:
Gregory Armstrong
金额:
$7.02万
依托单位国家:
美国
项目类别:
财政年份:
1997
资助国家:
美国
项目状态:
已结题
起止时间:
1997-04-01 至 2024-02-29
关键词:
AddressAreaBehavioralBiometryCancer CenterCancer Center Support GrantCancer ControlCancer SurvivorshipCardiopulmonaryChildhoodChildhood Cancer Survivor StudyChildhood Cancer TreatmentChronic DiseaseClinical ResearchClinical ServicesCognitive deficitsCohort StudiesCollaborationsComprehensive Cancer CenterConsensusDataDepartment chairDisciplineDivision of Cancer Epidemiology and GeneticsEducationEmploymentEndocrineEnrollmentEpidemiologyFatigueFundingFutureGeneticGenetic ResearchGoalsGrantGuidelinesHealthHealth behaviorIncidenceIndividualInfrastructureInstitutionInternationalInterventionKnowledgeLate EffectsLeadLeadershipLife ExpectancyLong-Term SurvivorsMalignant Childhood NeoplasmMedicineMelissaModelingMorbidity - disease rateNCI-Designated Cancer CenterNatureNeoplasmsNeurosciencesObservational StudyOncologyOutcomeOutcomes ResearchPediatric Oncology GroupPeer ReviewPopulationPostdoctoral FellowPremature MortalityPrevalencePsychologyPublicationsQuality of lifeRandomized Clinical TrialsResearchResearch InfrastructureResearch PersonnelResource SharingResourcesRiskRisk FactorsRoleSaint Jude Children&aposs Research HospitalScheduleSeminalStructureSurvival RateSurvivorsTherapeuticTrainingTranslatingTranslationsTreatment Side Effectsadverse outcomebasecancer epidemiologycancer preventioncareerchildhood cancer survivorclinical practicecohortdesignefficacy evaluationexperiencehigh riskhigh risk populationimprovedinnovationinsightinter-institutionalinternational centermembermultidisciplinarynext generation sequencingpreservationprogramspsychosocialrecruitreproductivescreeningsurvivorshiptreatment strategyworking group

项目摘要

项目成果

Gregory Armstrong的其他基金

相似基金

相关文献

中文摘要
翻译
项目概要/摘要-癌症控制和生存计划 癌症控制和生存计划(CCSP)的总体目标是进行高度创新的 临床,遗传和观察研究,并将我们的发现转化为有效的策略,以避免或 减轻治疗相关并发症,改善儿童癌症幸存者的生活质量。莱斯利博士 L.流行病学和癌症控制系主任罗宾逊和癌症中心主任梅丽莎哈德逊说, 癌症幸存者部门,领导该计划。他们在CCSP的两个NCI资助队列中发挥领导作用, 圣Jude Lifetime队列研究(SJLIFE)和儿童癌症幸存者研究(CCSS) 开创性的发现表征了儿童癌症经历的发病率的程度和范围, 包括由此造成的慢性疾病和随后的肿瘤负担及其对过早死亡的影响, mortality.从这项研究中获得的知识影响了当代儿科癌症的设计 治疗策略,并提供关键数据,以指导健康监测和健康保护干预措施 长期生存者。CCSP围绕广泛的共享研究基础设施构建,旨在 支持和加强项目成员进行的研究。这种基础设施反映了一种组合 以部门为重点的资源,由机构和SJCCC特定资源以及临床 机构外的服务。CCSP共有16名成员(11名正式成员和5名准成员), 流行病学和癌症控制,肿瘤学,心理学,全球儿科医学,和 儿科医学创新研究的设计和实施由7个特定学科的CCSP促进 工作组:神经科学、心脏病学、内分泌-生殖、遗传学、全球成果、 社会心理学-行为学和流行病学-生物统计学,他们定期开会(每两周或 每月)。在当前的赠款期间(2013-2017年),CCSP成员积极参与内部和内部, 研究合作项目。CCSP成员的研究出版物共计424篇, 该计划的高度合作性质,50%反映了计划内的合作,25.9%反映了计划间的合作, 方案合作。在当前的资助期间,CCSP成员发起/进行了试验 采取各种办法,加强对高危幸存者的健康检查,促进积极的健康行为, 修复治疗引起的认知缺陷,并减轻疲劳,共招募2283例患者, 干预性非治疗性试验。这些试验中有许多反映了观察性研究的直接翻译 由CCSP成员执行。CCSP成员参加了各种各样的多组合作 (涉及20多个国家癌症研究所指定的癌症中心,国家癌症研究所癌症流行病学和遗传学部门, 儿童肿瘤组和多个国际中心),以表征治疗和遗传因素 从而赋予特定迟发效应的高风险。CCSP成员每年共获得420万美元的同行评审 资金,包括410万美元的NCI资金。
英文摘要
PROJECT SUMMARY/ABSTRACT—Cancer Control and Survivorship Program The overarching goal of the Cancer Control and Survivorship Program (CCSP) is to conduct highly innovative clinical, genetic, and observational research, and translate our findings into effective strategies to avert or mitigate treatment-related complications and improve the quality of life of childhood cancer survivors. Drs. Leslie L. Robison, chair of the Department of Epidemiology and Cancer Control, and Melissa Hudson, director of the Division of Cancer Survivorship, lead the Program. Their leadership roles in the CCSP's two NCI-funded cohorts, St. Jude Lifetime Cohort Study (SJLIFE) and the Childhood Cancer Survivor Study (CCSS), have facilitated seminal discoveries characterizing the magnitude and scope of morbidity of the childhood cancer experience, including the resulting burden of chronic disease and subsequent neoplasms and their contribution to premature mortality. Knowledge gained from this research has influenced the design of contemporary pediatric cancer treatment strategies and provided critical data to guide health surveillance and health preserving interventions for long-term survivors. The CCSP is structured around an extensive shared research infrastructure designed to support and enhance the research conducted by Program members. This infrastructure reflects a combination of departmental-focused resources, augmented by institutional and SJCCC-specific resources plus clinical services external to the institution. The CCSP has a total of 16 members (11 Full and 5 Associate), representing the Departments of Epidemiology & Cancer Control, Oncology, Psychology, Global Pediatric Medicine, and Pediatric Medicine. The design and conduct of innovative research is facilitated by 7 discipline-specific CCSP working groups: Neurosciences, Cardiopulmonary, Endocrine-Reproductive, Genetics, Global Outcomes, Psychosocial-Behavioral, and Epidemiology-Biostatistics, who meet on a regular schedule (bi-weekly or monthly). During the current grant period (2013-2017), CCSP members have actively engaged in intra- and inter- programmatic research collaborations. Research publications by CCSP members totaled 424 and demonstrate the highly collaborative nature of the Program with 50% reflecting an intra-programmatic and 25.9% inter- programmatic collaboration. During the current funding period, CCSP members initiated/conducted trials addressing approaches to enhance health screening for at-risk survivors, promote positive health behaviors, remediate treatment-induced cognitive deficits, and reduce fatigue, contributing a total of 2283 enrollments to interventional non-therapeutic trials. Many of these trials reflect a direct translation of observational research conducted by CCSP members. CCSP members have participated in a wide variety of multi-group collaborations (involving more than 20 NCI-designated Cancer Centers, the NCI Division of Cancer Epidemiology and Genetics, the Children's Oncology Group, and multiple international centers) to characterize treatment and genetic factors conferring high risk for specific late effects. CCSP members have a total of $4.2M in annual peer-reviewed funding, including $4.1M in NCI funding.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
CHILDHOOD CANCER SURVIVOR STUDY
CCSS Expansion Study Supplement
ExtractEHR Pilot Childhood Cancer Data Initiative (CCDI)
Sen-Survivors: An open-label intervention trial for frailty and senescence
国内基金
海外基金
层出镰刀菌氮代谢调控因子AreA 介导伏马菌素 FB1 生物合成的作用机理
  • 批准号:
    2021JJ40433
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2021
  • 负责人:
    孙磊
  • 依托单位:
寄主诱导梢腐病菌AreA和CYP51基因沉默增强甘蔗抗病性机制解析
  • 批准号:
    32001603
  • 项目类别:
    青年科学基金项目
  • 资助金额:
    24.0万元
  • 批准年份:
    2020
  • 负责人:
    段真珍
  • 依托单位:
AREA国际经济模型的移植.改进和应用
  • 批准号:
    18870435
  • 项目类别:
    面上项目
  • 资助金额:
    2.0万元
  • 批准年份:
    1988
  • 负责人:
    史树中
  • 依托单位: